![Early safety and efficacy of the combination of bedaquiline and delamanid for the treatment of patients with drug-resistant tuberculosis in Armenia, India, and South Africa: a retrospective cohort study - The Lancet Early safety and efficacy of the combination of bedaquiline and delamanid for the treatment of patients with drug-resistant tuberculosis in Armenia, India, and South Africa: a retrospective cohort study - The Lancet](https://www.thelancet.com/cms/asset/852dfdac-004e-408c-8faa-143103267813/gr1.jpg)
Early safety and efficacy of the combination of bedaquiline and delamanid for the treatment of patients with drug-resistant tuberculosis in Armenia, India, and South Africa: a retrospective cohort study - The Lancet
![Delamanid, linezolid, levofloxacin, and pyrazinamide for the treatment of patients with fluoroquinolone-sensitive multidrug-resistant tuberculosis (Treatment Shortening of MDR-TB Using Existing and New Drugs, MDR-END): study protocol for a phase II/III ... Delamanid, linezolid, levofloxacin, and pyrazinamide for the treatment of patients with fluoroquinolone-sensitive multidrug-resistant tuberculosis (Treatment Shortening of MDR-TB Using Existing and New Drugs, MDR-END): study protocol for a phase II/III ...](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs13063-018-3053-1/MediaObjects/13063_2018_3053_Fig1_HTML.png)
Delamanid, linezolid, levofloxacin, and pyrazinamide for the treatment of patients with fluoroquinolone-sensitive multidrug-resistant tuberculosis (Treatment Shortening of MDR-TB Using Existing and New Drugs, MDR-END): study protocol for a phase II/III ...
![Delamanid Added to an Optimized Background Regimen in Children with Multidrug-Resistant Tuberculosis: Results of a Phase I/II Clinical Trial | Antimicrobial Agents and Chemotherapy Delamanid Added to an Optimized Background Regimen in Children with Multidrug-Resistant Tuberculosis: Results of a Phase I/II Clinical Trial | Antimicrobial Agents and Chemotherapy](https://journals.asm.org/cms/10.1128/aac.02144-21/asset/450a912d-7e15-46ba-8d55-a3f610b4ac9f/assets/images/large/aac.02144-21-f001.jpg)
Delamanid Added to an Optimized Background Regimen in Children with Multidrug-Resistant Tuberculosis: Results of a Phase I/II Clinical Trial | Antimicrobial Agents and Chemotherapy
![Sustained absorption of delamanid from lipid-based formulations as a path to reduced frequency of administration | SpringerLink Sustained absorption of delamanid from lipid-based formulations as a path to reduced frequency of administration | SpringerLink](https://media.springernature.com/lw685/springer-static/image/art%3A10.1007%2Fs13346-020-00851-z/MediaObjects/13346_2020_851_Fig3_HTML.png)
Sustained absorption of delamanid from lipid-based formulations as a path to reduced frequency of administration | SpringerLink
![Delamanid improves outcomes and reduces mortality in multidrug-resistant tuberculosis | European Respiratory Society Delamanid improves outcomes and reduces mortality in multidrug-resistant tuberculosis | European Respiratory Society](https://erj.ersjournals.com/content/erj/41/6/1393/F1.large.jpg)
Delamanid improves outcomes and reduces mortality in multidrug-resistant tuberculosis | European Respiratory Society
![Pharmacokinetics and Metabolism of Delamanid, a Novel Anti-Tuberculosis Drug, in Animals and Humans: Importance of Albumin Metabolism In Vivo | Drug Metabolism & Disposition Pharmacokinetics and Metabolism of Delamanid, a Novel Anti-Tuberculosis Drug, in Animals and Humans: Importance of Albumin Metabolism In Vivo | Drug Metabolism & Disposition](https://dmd.aspetjournals.org/content/dmd/43/8/1267/F1.large.jpg)
Pharmacokinetics and Metabolism of Delamanid, a Novel Anti-Tuberculosis Drug, in Animals and Humans: Importance of Albumin Metabolism In Vivo | Drug Metabolism & Disposition
![Pharmacokinetics and Metabolism of Delamanid, a Novel Anti-Tuberculosis Drug, in Animals and Humans: Importance of Albumin Metabolism In Vivo | Semantic Scholar Pharmacokinetics and Metabolism of Delamanid, a Novel Anti-Tuberculosis Drug, in Animals and Humans: Importance of Albumin Metabolism In Vivo | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/e4feeb046d2cc7b9525327ba9dd7ef64df0afe07/34-Table2-1.png)
Pharmacokinetics and Metabolism of Delamanid, a Novel Anti-Tuberculosis Drug, in Animals and Humans: Importance of Albumin Metabolism In Vivo | Semantic Scholar
![TB Treatments: New Drugs Bedaquiline And Delamanid Show Early Efficacy Against Drug-Resistant Tuberculosis - Thailand Medical News TB Treatments: New Drugs Bedaquiline And Delamanid Show Early Efficacy Against Drug-Resistant Tuberculosis - Thailand Medical News](https://www.thailandmedical.news/uploads/news/5f35e2c85e985_TB-Treatments.jpg)
TB Treatments: New Drugs Bedaquiline And Delamanid Show Early Efficacy Against Drug-Resistant Tuberculosis - Thailand Medical News
![Figures and data in The anti-tubercular drug delamanid as a potential oral treatment for visceral leishmaniasis | eLife Figures and data in The anti-tubercular drug delamanid as a potential oral treatment for visceral leishmaniasis | eLife](https://iiif.elifesciences.org/lax/09744%2Felife-09744-fig1-v1.tif/full/full/0/default.jpg)
Figures and data in The anti-tubercular drug delamanid as a potential oral treatment for visceral leishmaniasis | eLife
![Pharmacokinetics and Metabolism of Delamanid, a Novel Anti-Tuberculosis Drug, in Animals and Humans: Importance of Albumin Metabolism In Vivo | Drug Metabolism & Disposition Pharmacokinetics and Metabolism of Delamanid, a Novel Anti-Tuberculosis Drug, in Animals and Humans: Importance of Albumin Metabolism In Vivo | Drug Metabolism & Disposition](https://dmd.aspetjournals.org/content/dmd/43/8/1267/F2.large.jpg)
Pharmacokinetics and Metabolism of Delamanid, a Novel Anti-Tuberculosis Drug, in Animals and Humans: Importance of Albumin Metabolism In Vivo | Drug Metabolism & Disposition
![Sustained absorption of delamanid from lipid-based formulations as a path to reduced frequency of administration | SpringerLink Sustained absorption of delamanid from lipid-based formulations as a path to reduced frequency of administration | SpringerLink](https://media.springernature.com/lw685/springer-static/image/art%3A10.1007%2Fs13346-020-00851-z/MediaObjects/13346_2020_851_Fig1_HTML.png)
Sustained absorption of delamanid from lipid-based formulations as a path to reduced frequency of administration | SpringerLink
![Microorganisms | Free Full-Text | Treatment of Multidrug-Resistant and Extensively Drug-Resistant Tuberculosis in Children: The Role of Bedaquiline and Delamanid Microorganisms | Free Full-Text | Treatment of Multidrug-Resistant and Extensively Drug-Resistant Tuberculosis in Children: The Role of Bedaquiline and Delamanid](https://www.mdpi.com/microorganisms/microorganisms-09-01074/article_deploy/html/images/microorganisms-09-01074-g001.png)